Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Osteoporos Int ; 13(4): 309-16, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12030546

RESUMEN

In a randomized double-masked placebo-controlled parallel-group trial 166 hysterectomized (+/- oophorectomy) perimenopausal and postmenopausal women aged 45-55 years with a follicle stimulating hormone level above 20 IU/l were treated with one daily dose of either 0.5 mg 17beta-estradiol (E2), 1 mg E2, 2 mg E2 or placebo for 2 years. Bone mineral density (BMD) and biochemical bone markers were determined. All three doses of E2 were significantly better than placebo with respect to change in BMD at the lumbar spine (L1-L4) (p<0.0001 for all pairwise comparisons) and hip (femoral neck, trochanter, Ward's triangle). The mean percentage change from baseline at the lumbar spine was -0.2%, 0.8% and 1.8% in the 0.5, 1 and 2 mg E2 groups respectively compared with -3.5% in the placebo group. Both 1 and 2 mg E2 were significantly better than placebo in increasing the BMD at the femoral neck (p<0.001), trochanter (p<0.01) and Ward's triangle (p<0.0001), while 0.5 mg E2 was significantly better than placebo at the femoral neck (p<0.001) and Ward's triangle (p<0.0001). The overall difference in mean percentage change in BMD at the femoral neck versus placebo (-0.2%) was 3.8% for 0.5 mg, 4.0% for 1 mg and 3.9% for 2 mg E2; the corresponding numbers for trochanter were 1.3%, 3.3% and 3.2%, respectively, and -2.2%,, 2.9, 2.9% and 4.0%, respectively, for Ward's triangle. More than half the women who received placebo presented with a decrease in BMD at the hip. The percentage of women in the 0.5 mg E2 group who maintained or increased BMD at the femoral neck, trochanter and Ward's triangle was 69%, 56% and 44%, respectively. For 1 mg E2 the numbers were 69%, 78% and 61% respectively, and for 2 mg E2 were 59%, 68% and 59% respectively. Osteocalcin, serum pyridinium crosslinks, urinary pyridinium cross-links and urinary hydroxyproline/creatinine decreased significantly (p<0.0001, p<0.05) in the 0.5, 1 and 2 mg E2 groups compared with the placebo group after 6 and 24 months of treatment.


Asunto(s)
Estradiol/uso terapéutico , Histerectomía , Osteoporosis Posmenopáusica/tratamiento farmacológico , Biomarcadores/sangre , Biomarcadores/orina , Densidad Ósea , Creatinina/orina , Método Doble Ciego , Esquema de Medicación , Femenino , Fémur , Cuello Femoral , Humanos , Vértebras Lumbares , Persona de Mediana Edad , Osteocalcina/sangre , Compuestos de Piridinio/sangre , Compuestos de Piridinio/orina
2.
Br J Obstet Gynaecol ; 105(8): 904-11, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9746385

RESUMEN

OBJECTIVE: To compare the effects of two postmenopausal regimens on menopausal symptoms, bleeding episodes, side effects and acceptability. DESIGN: Double-blind, randomised controlled trial. SETTING: Twenty-nine sites in Denmark, nine in Norway and six in Sweden. PARTICIPANTS: Four hundred and thirty-seven postmenopausal women with menopausal complaints. None of these women had had a hysterectomy. INTERVENTIONS: Daily treatment with tibolone 2.5 mg (n = 218) or 17beta-oestradiol 2 mg plus norethisterone acetate 1 mg (E2/NETA) (n = 219). MAIN OUTCOME MEASURES: Hot flushes, sweating episodes, vaginal dryness, assessment of sexual life and bleeding patterns; at baseline and after 4, 12, 24 and 48 weeks. RESULTS: Treatment with either preparation significantly reduced mean scores for hot flushes, sweating episodes and vaginal dryness. The overall discontinuation rate was 28% (tibolone 25%, E2/NETA 31%; P = 0.14), mostly during the first six months. There was a markedly lower cumulative incidence of bleeding or spotting episodes with tibolone compared with E2/NETA (P < 0.0001), mainly during the first six treatment cycles. CONCLUSIONS: Both tibolone and E2/NETA effectively alleviate menopausal symptoms. However, tibolone caused significantly fewer bleeding or spotting episodes, which were reflected by lower overall rates of bleeding, as well as lower drop-out rates due to bleeding.


Asunto(s)
Anabolizantes/uso terapéutico , Terapia de Reemplazo de Estrógeno/métodos , Menopausia/efectos de los fármacos , Noretindrona/uso terapéutico , Norpregnenos/uso terapéutico , Congéneres de la Progesterona/uso terapéutico , Método Doble Ciego , Femenino , Sofocos/tratamiento farmacológico , Humanos , Persona de Mediana Edad , Posmenopausia , Conducta Sexual , Sudoración/efectos de los fármacos , Hemorragia Uterina/inducido químicamente , Enfermedades Vaginales/inducido químicamente
3.
Acta Obstet Gynecol Scand ; 70(6): 501-6, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1842676

RESUMEN

Of continent women undergoing the Manchester procedure for genito-urinary prolapse, about 25% develop urinary stress-incontinence. In order to study whether this is due to pre-existing anatomical factors or to the surgical procedure itself, a prospective study was set up. Fifty-eight continent women operated on for genito-urinary prolapse, underwent urethrocystography prior to and 3 months following surgery. Sixteen of the 58 (28%) developed stress-incontinence following the operation. Radiological parameters preoperatively were of little help in distinguishing the patients developing incontinence from those remaining continent. The stress-incontinence following a Manchester procedure for genital prolapse seems to depend on two surgical factors: an insufficient elevation of the bladder-neck and a radical reduction of the cystocele. A parameter combining the two factors: the percentage reduction of the cystocele minus the percentage elevation of the bladder-neck, was significantly lower in women remaining continent than in those who developed stress-incontinence.


Asunto(s)
Complicaciones Posoperatorias/epidemiología , Incontinencia Urinaria de Esfuerzo/epidemiología , Anciano , Femenino , Humanos , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/prevención & control , Valor Predictivo de las Pruebas , Estudios Prospectivos , Radiografía , Factores de Riesgo , Uretra/diagnóstico por imagen , Vejiga Urinaria/diagnóstico por imagen , Enfermedades de la Vejiga Urinaria/cirugía , Incontinencia Urinaria de Esfuerzo/diagnóstico por imagen , Incontinencia Urinaria de Esfuerzo/prevención & control , Prolapso Uterino/cirugía
4.
Acta Obstet Gynecol Scand ; 68(6): 545-9, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2520812

RESUMEN

A study was performed to find out how often continent women develop urinary stress-incontinence after a Manchester operation for genito-urinary prolapse, and to ascertain whether factors in the selection of patients, or steps in the surgical procedure are responsible for producing stress-incontinence postoperatively. Seventy-three of 102 consecutive patients were continent before operation. Sixteen of the 73 women (22%) became stress incontinent. Advanced age increased the risk of developing urinary stress-incontinence. Twenty-five per cent of the women more than 60 years old developed stress-incontinence, but only 1 of 13 below the age of 60. Preoperative urethral closure pressure was significantly lower in those developing urinary stress-incontinence, and closure pressure was further reduced by surgery in this group, significantly more than in the women remaining continent. Surgery significantly reduced the pressure transmission ratio in the patients who developed urinary stress-incontinence, and less in the continent ones. The preoperative pressure transmission ratio, however, was not related to the risk of developing urinary stress-incontinence after the operation. The urodynamic examinations pre- and postoperatively demonstrated important changes in the urodynamic parameters produced by the Manchester procedure, but did not prove useful in determining which patients will develop urinary stress-incontinence.


Asunto(s)
Complicaciones Posoperatorias/epidemiología , Incontinencia Urinaria de Esfuerzo/epidemiología , Urodinámica/fisiología , Prolapso Uterino/cirugía , Factores de Edad , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Factores de Riesgo , Factores de Tiempo , Incontinencia Urinaria de Esfuerzo/etiología
5.
Eur Urol ; 14(1): 27-9, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-3342802

RESUMEN

A comparative study of a new fiber-optic transducer versus a microtip transducer was performed in 13 females. A good correlation was found on bladder pressure. The urethral pressure diverged considerably, as the pressures measured with the fiber-optic transducer were about two thirds of the pressures found with the microtip. The functional urethral length measured with the fiber-optic transducer was also shorter.


Asunto(s)
Transductores de Presión , Transductores , Uretra/fisiología , Vejiga Urinaria/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Tecnología de Fibra Óptica/instrumentación , Humanos , Persona de Mediana Edad , Fibras Ópticas , Presión , Incontinencia Urinaria/diagnóstico
8.
Zentralbl Gynakol ; 103(22): 1337-43, 1981.
Artículo en Inglés | MEDLINE | ID: mdl-7200307

RESUMEN

Urethral pressure is made up of three components, equal in size: the striated muscle component, the smooth muscle component, and the vascular component. Anti-embolism stockings have been helpful in bringing about significant improvement in blood flow through the lower extremities. A pilot study was undertaken with 15 women to find out whether or not the same approach led to increase in urethral pressure. Simultaneous urethrocystometry was applied to women with and without stockings. Significant rise in urethral pressure was recorded from women with urinary stress incontinence who used stockings. Four of eight incontinent women were improved to continence by means of stockings.


Asunto(s)
Uretra/irrigación sanguínea , Incontinencia Urinaria de Esfuerzo/terapia , Fenómenos Fisiológicos del Sistema Urinario , Adolescente , Adulto , Anciano , Vendajes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Presión , Flujo Sanguíneo Regional , Uretra/fisiopatología , Vejiga Urinaria/fisiopatología
10.
Acta Pharmacol Toxicol (Copenh) ; 46 Suppl 1: 31-8, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7386219

RESUMEN

Terodiline, a drug with anticholinergic and calcium antagonistic properties, effectively relaxed carbachol-contracted, isolated human bladder preparations. In the concentrations used, terodiline displaced to the right the concentration-response curve obtained on cumulative addition of carbachol. The maximum response was slightly reduced only at the highest terodiline concentration used (5 microM), suggesting a mainly competitive antimuscarinic effect. Nine patients, aged 12--78 years, suffering from urge urinary incontinence were investigated by simultaneous urethro-cystometry before and after treatment with terodiline 12.5 mg twice or three times daily for 10 days. The patients reported subjective improvement with almost no side effects. Objectively, the number of uninhibited bladder contractions and the amplitude of the contractions decreased. The bladder capacity was almost doubled. There were no marked effects on bladder and urethral pressures at rest, and only two of the investigated patients had slight residual urine after treatment. The results suggest that terodiline is a promising alternative to existing drugs for inhibition of undesired detrusor activity.


Asunto(s)
Butilaminas/farmacología , Parasimpatolíticos , Incontinencia Urinaria/tratamiento farmacológico , Adolescente , Adulto , Anciano , Butilaminas/uso terapéutico , Carbacol/farmacología , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Músculo Liso/efectos de los fármacos , Músculo Liso/inervación , Presión , Uretra/efectos de los fármacos , Uretra/fisiopatología , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/fisiopatología , Urodinámica/efectos de los fármacos
11.
Acta Obstet Gynecol Scand ; 59(3): 265-70, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7191614

RESUMEN

The present investigation was performed to study the urodynamic effects of hormones on the lower urinary tract in women. Twenty-four stress incontinent and 6 continent women were randomly given E2 and E3 orally in doses of 4--8 mg per day for 3 weeks. Another group of 8 women were given a single i.m. injection of 1000 mg gestagen. All the women were examined with simultaneous urethrocystometry, including urethral pressure profile measurement, before and after treatment. After estrogen treatment the transmission of intraabdominal pressure to the urethra increased. Furthermore, there was a significant increase in maximum urethal pressure and urethral length at rest. After gestagen treatment no significant changes of the recorded parameters were observed.


Asunto(s)
Estradiol/farmacología , Hidroxiprogesteronas/farmacología , Uretra/efectos de los fármacos , Incontinencia Urinaria de Esfuerzo/tratamiento farmacológico , Urodinámica/efectos de los fármacos , Administración Oral , Adulto , Anciano , Relación Dosis-Respuesta a Droga , Estradiol/administración & dosificación , Estradiol/uso terapéutico , Femenino , Humanos , Hidroxiprogesteronas/administración & dosificación , Hidroxiprogesteronas/uso terapéutico , Masculino , Persona de Mediana Edad , Presión , Incontinencia Urinaria de Esfuerzo/fisiopatología
12.
Acta Obstet Gynecol Scand ; 59(4): 331-5, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7192471

RESUMEN

One hundred and sixty-nine urinary continent females were examined with simultaneous urethro-cystometry, using a dual microtip-catheter. It was shown that the maximum urethral pressure and the urethral length increased from infancy to the age of 20--25 years. Thereafter, the values of these parameters decreased with increasing age. The bladder pressure remained constant in the different age groups. In six women, aged between 20 and 25 years, the parameters were measured three times during a menstrual cycle. No correlation between the fluctuating estrogens, gestagens, catecholamines and the urethral pressure or the urethral lengths was found.


Asunto(s)
Uretra/fisiología , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Presión , Transductores de Presión , Uretra/anatomía & histología , Vejiga Urinaria/fisiología
13.
Invest Urol ; 17(4): 343-7, 1980 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7188694

RESUMEN

To determine the components of the intraurethral pressure at rest, five continent women were studied with simultaneous urethrocystometry, including urethral pressure profile measurements, before, during and after curarization, as well as after clamping of the arterial blood supply to the urethra. The results showed that the striated muscle component in the urethra and pelvic floor is responsible for one-third of the total intraurethral pressure. Another one-third is exerted by the urethral vascular bed. The remaining one-third is most probably attributable to the smooth musculature and connective tissues in the urethra and the periurethral tissues.


Asunto(s)
Uretra/fisiología , Adulto , Alcuronio/farmacología , Presión Sanguínea/efectos de los fármacos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Músculos/efectos de los fármacos , Músculos/fisiología , Presión , Uretra/irrigación sanguínea , Uretra/efectos de los fármacos
14.
Acta Pharmacol Toxicol (Copenh) ; 46 Suppl 1: 39-43, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-6966882

RESUMEN

In a double-blind, cross-over study, the effects of terodiline were evaluated in 12 women with motor urge incontinence. The patients were investigated by simultaneous urethro-cystometry before and after treatment fo 2-week periods with placebo and terodiline 12.5 mg twice daily. The effects on subjective symptoms were also assessed. In all patients but one, terodiline increased the bladder capacity and also the bladder volume at which urgency was experienced. No effects on the urethral pressure profile or residual urine were found. Subjective improvement was reported by all but one of the patients. Placebo treatment had no effect on the measured parameters or on the subjective symptoms. No side effects were reported during any of the treatment periods. --It is concluded that terodiline can be used for treatment of female motor urge incontinence, and that it is a promising alternative to drugs presently used for this disorder.


Asunto(s)
Butilaminas/uso terapéutico , Parasimpatolíticos , Incontinencia Urinaria/tratamiento farmacológico , Adulto , Anciano , Estudios Transversales , Método Doble Ciego , Evaluación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Placebos , Presión , Uretra/efectos de los fármacos , Uretra/fisiopatología , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/fisiopatología , Urodinámica/efectos de los fármacos
15.
Tidsskr Nor Laegeforen ; 99(11): 521-4, 1979 Apr 20.
Artículo en Noruego | MEDLINE | ID: mdl-442025
16.
Urol Int ; 34(6): 421-9, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-494443

RESUMEN

A study of the effect of the calcium antagonist nifedipine on the detrusor contractions of 10 women with an unstable bladder is reported. An inhibiting effect was observed in all patients after intake of nifedipine. The number of contractions and the contraction amplitudes decreased, and the bladder capacity increased. Resting intraurethral and intravesical pressures were not affected. Subjective improvement was reported by all patients during a week of continuous nifedipine treatment. Side effects were few and tolerable. It is suggested that nifedipine can be of value in the treatment of unstable bladder.


Asunto(s)
Enuresis/tratamiento farmacológico , Nifedipino/uso terapéutico , Piridinas/uso terapéutico , Incontinencia Urinaria/tratamiento farmacológico , Adolescente , Adulto , Niño , Femenino , Humanos , Persona de Mediana Edad , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos
17.
Scand J Urol Nephrol ; 13(3): 259-64, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-575232

RESUMEN

Six continent and 4 incontinent females were examined by a combined technique of simultaneous urethrocystometry and rapid X-ray-film exposures. The study confirmed that pressure changes occurring in the urethra and bladder at initiation of voiding were not caused by artefacts of the measuring technique. It was found that the continent females initiated micturition mainly by a rapid decrease in urethral pressure followed by an increase in the bladder pressure. The stress incontinent females strained out the urine without initial urethral relaxation. Since the X-ray-technique did not add any new clinical information about micturition in females the pressure recording technique is recommended for routine investigation of micturition in females.


Asunto(s)
Uretra/fisiología , Vejiga Urinaria/fisiología , Incontinencia Urinaria de Esfuerzo/fisiopatología , Micción , Urodinámica , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Presión , Radiografía , Uretra/diagnóstico por imagen , Vejiga Urinaria/diagnóstico por imagen , Cateterismo Urinario
18.
Acta Pharmacol Toxicol (Copenh) ; 43(2): 111-8, 1978 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-696340

RESUMEN

Smooth muscle preparations of the urethra, bladder, and ureter were obtained from patients undergoing operations for various urological disorders. The urethral preparations were contracted by noradrenaline (0.1-3 microgram . ml-1), prostaglandin F2alpha (1-10 microgram . ml-1), and potassium (127 mM), the bladder preparations by carbacholine (0.004-1 microgram . ml-1), prostaglandin F2alpha (1-10 microgram . ml-1), potassium (127 mM), and barium chloride (3 mM), and the ureter preparations by potassium (127 mM), and barium chloride (3 mM). Irrespective of the mode of activation, pretreatment with nifedipine (0.1 microgram . ml-1) for 10 min. reduced the responses. Nifedipine also relaxed preparations contracted by the contractile agents used. In 19 female patients, aged 20 to 73 years, undergoing investigation because of urgency and/or urge incontinence, simultaneous urethrocystometry at rest was performed before and after oral administration of 20 to 40 mg nifedipine. Bladder capacity and residual urine were also determined. Nifedipine did not affect the pressures within the bladder and urethra, nor did it increase the bladder capacity. However, after nifedipine intake there was a statistically significant increase in residual urine. The results suggest that nifedipine can inhibit contractile activity induced by drugs with different modes of action; the drug does not affect the tone in bladder and urethra.


Asunto(s)
Músculo Liso/efectos de los fármacos , Nifedipino/farmacología , Piridinas/farmacología , Sistema Urinario/efectos de los fármacos , Administración Oral , Adulto , Anciano , Carbacol/farmacología , Cloruros/farmacología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Contracción Muscular/efectos de los fármacos , Nifedipino/administración & dosificación , Norepinefrina/farmacología , Potasio/farmacología , Presión , Prostaglandinas F/farmacología , Uréter/efectos de los fármacos , Uretra/efectos de los fármacos , Vejiga Urinaria/efectos de los fármacos
19.
Acta Obstet Gynecol Scand ; 57(5): 457-62, 1978.
Artículo en Inglés | MEDLINE | ID: mdl-569418

RESUMEN

Sixteen healthy women, and 13 with stress incontinence were investigated by simultaneous urethrocystometry during the initiation of voiding. In the healthy women, there was a decrease in the maximum intra-urethral pressure immediately before micturition. A few seconds later (mean 3.0 sec), the intravesical pressure increased. As a result, the urethral closure pressure decreased to zero, and urine started to escape from the urethra. In the patients with stress in continence, three different ways of initiating micturition were observed. Five patients initiated voiding by the Valsalva manoeuvre, 3 mainly by decreasing the maximum urthral pressure, and 5 mainly in the same way as the healthy women. The results suggest that preoperative analysis of the micturition pattern by means of simultaneous urethrocystometry can be of value for the choice of operative procedure, and thereby make it possible to avoid or reduce postoperative retention of urine.


Asunto(s)
Incontinencia Urinaria de Esfuerzo/fisiopatología , Micción , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Presión , Uretra/fisiopatología , Vejiga Urinaria/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA